To therapeutically modulate gut microbial ecosystems, a better understanding of gut ecology is key. High-throughput in vitro ecology provides a tool with the necessary power to address these needs and interpersonal treatment response variation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Data-driven prediction of colonization outcomes for complex microbial communities
Nature Communications Open Access 16 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vázquez-Castellanos, J. F., Biclot, A., Vrancken, G., Huys, G. R. & Raes, J. Design of synthetic microbial consortia for gut microbiota modulation. Curr. Opin. Pharmacol. 49, 52–59 (2019).
El Hage, R., Hernandez-Sanabria, E. & Van de Wiele, T. Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications. Front. Microbiol. 8, 1889 (2017).
Clemente, J. C., Manasson, J. & Scher, J. U. The role of the gut microbiome in systemic inflammatory disease. BMJ 360, j5145 (2018).
Mills, S., Ross, R. P. & Hill, C. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology. FEMS Microbiol. Rev. 41, S129–S153 (2017).
Vieira-Silva, S. et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310–315 (2020).
Vrancken, G., Gregory, A. C., Huys, G. R., Faust, K. & Raes, J. Synthetic ecology of the human gut microbiota. Nat. Rev. Microbiol. 17, 754–76 (2019).
Tramontano, M. et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat. Microbiol. 3, 514–522 (2018).
Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
Hernandez-Sanabria, E. et al. Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation. NPJ Biofilms Microbiomes 6, 1–12 (2020).
Muller, E. E. et al. Using metabolic networks to resolve ecological properties of microbiomes. Curr. Opin. Syst. Biol. 8, 73–80 (2018).
Acknowledgements
The authors are grateful to the Raes lab members for many stimulating discussions in this area, in particular A. Biclot, G. Huys, G. Vrancken, G. Falony, S. Vieira-Silva, A. Gregory, as well as K. Faust and T. Rask Licht. E.H.-S. is supported by the Novo Nordisk Fundation (PRIMA Project).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.R. has acted or is acting as scientific advisor to Aphea.Bio, Biofortis, GSK vaccines, Janssen Pharmaceuticals, Merck, MRM health and Takeda. E.H.-S. and J.F.V.-C. declare no competing interests.
Rights and permissions
About this article
Cite this article
Hernandez-Sanabria, E., Vázquez-Castellanos, J.F. & Raes, J. In vitro ecology: a discovery engine for microbiome therapies. Nat Rev Gastroenterol Hepatol 17, 711–712 (2020). https://doi.org/10.1038/s41575-020-00364-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-020-00364-7
This article is cited by
-
Data-driven prediction of colonization outcomes for complex microbial communities
Nature Communications (2024)
